Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Fauci says first U.S. COVID-19 vaccines could ship late December or early January

Published 10/29/2020, 02:44 PM
Updated 10/29/2020, 03:35 PM
© Reuters. FILE PHOTO: U.S. Senate hearing on plan to research, manufacture and distribute coronavirus vaccine, on Capitol Hill in Washington

By Julie Steenhuysen

CHICAGO (Reuters) - If all goes well, the first doses of a safe and effective coronavirus vaccine will likely become available to some high-risk Americans in late December or early January, Dr. Anthony Fauci, the top U.S. infectious diseases expert, said on Thursday.

Based on current projections from vaccine front-runners Moderna (NASDAQ:MRNA) Inc and Pfizer Inc (NYSE:PFE), Americans will likely know "sometime in December whether or not we have a safe and effective vaccine," Fauci, director of the National Institute of Allergy and Infectious Diseases, said in a live chat on Twitter and Facebook (NASDAQ:FB).

"The first interim look (at trial results) should be, we hope, within the next few weeks," he said.

Both companies started the final stage of clinical testing in late July with tens of thousands of people taking part in each trial.

Moderna earlier on Thursday said it was on track to deliver interim data from its large, late-stage trial next month.

Pfizer, which was expected to announce interim data in October, is now unlikely to release data before November, probably after the Nov 3. U.S. presidential election.

The data will then need to be reviewed by the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, which will make recommendations on who gets the first doses if the trials prove successful.

Practically speaking, Fauci said, the first vaccine doses would likely be deployed to individuals deemed most in need "by the end of December or the beginning of January."

Fauci's comments were part of a conversation with Dr. Francis Collins, director of the National Institutes of Health, who took questions from listeners.

Even with an effective vaccine to protect against the virus, Fauci said it will take time to get back to something approaching normal as vaccine-induced immunity builds both nationally and globally. He said life will likely not get back to normal "until the end of 2021 at least."

In the interim, Collins urged Americans to be prepared to continue wearing masks and maintain social distancing.

© Reuters. FILE PHOTO: Fauci, Redfield testify at U.S. Senate hearing on coronavirus response in Washington

"I know Americans are tired of these measures. Tired of wearing masks. Tired of not being able to congregate together," Collins said. "But we've got a long road yet to go."

Latest comments

Take the Chinese - cheaper and tested on millions
Corruption in bldg#1-10Nih director looks mentally sick, fauchii has ego problems.
i think Fauci is enjoying his FAME, i think that he is not that good.......he also did not know what to do  for a long while......
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.